Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14714715 | 0.85 | RAB9A (0.36) | ALDH1A1KDM4EHTTSMN1; SMN2NPC1 | |
| SCHEMBL29387123 | 0.82 | MAPT (0.34) | ALDH1A1KDM4ETDP1LMNAHTT | |
| SCHEMBL29714449 | 0.81 | NPC1 (0.35) | ALDH1A1KDM4ETDP1LMNAHTT | |
| SCHEMBL28831144 | 0.81 | NPC1 (0.35) | ALDH1A1KDM4ETDP1LMNAHTT | |
| SCHEMBL26123782 | 0.79 | RAB9A (0.40) | ALDH1A1KDM4ETDP1LMNAHTT | |
| SCHEMBL38665543 | 0.76 | RAB9A (0.40) | ALDH1A1KDM4ELMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL30381152 | 0.76 | RAB9A (0.40) | ALDH1A1KDM4ELMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL5691966 | 0.67 | NPC1 (0.30) | NPC1RAB9A | |
| SCHEMBL8229967 | 0.67 | RAB9A (0.35) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL28069714 | 0.67 | FABP5 (0.45) | ALDH1A1KDM4ELMNAHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250249110-A1 | ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF | SICHUAN UNIVERSITY (CN) | 2025-08-07 | — | — | US | disclosed |
| EP-3480208-B1 | ANTI-MICROBIAL PEPTIDE DERIVATIVE AND APPLICATION THEREOF | UNIV SICHUAN (CN) | 2024-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250249110-A1 | ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF | VIP, SLC47A1, SLC47A2 | ALDH1A1 4657/4885KDM4E 4347/4885TDP1 3360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.